In patients with selective total IgA-deficiency, tTG-IgA should be substituted with immunoglobulin G (IgG) based testing [tTG, antibodies to deamidated gliadin peptides (DGP) or EMA]. The gene discussed is CD79A; the disease is selective IgA deficiency disease.